ADAM33 and cystic fibrosis: Pulmonary function in CF reflects a complex interplay between CFTR mutations, secondary modifier loci, and environmental drivers, and the associations observed in our cohort suggest that ADAM33 variation may help explain functional heterogeneity even among patients carrying similar CFTR genotypes.